What We're Reading
Industry reads hand-picked by our editors
Oct 21, 2025
-
Axios
How Eli Lilly became the new king of the anti-obesity drug market
-
Stat
FDA review of drugs is slowing while application delays are growing, analysis finds
-
Reuters
Kenvue urges US FDA to reject request for Tylenol’s autism warning
-
Philadelphia Business Journal
Philadelphia life sciences sector cuts nearly 1,000 jobs in 2025 as investor caution grows
Oct 20, 2025
-
Reuters
Novo Nordisk hires US pharma veteran as Trump pricing pressure mounts
-
The New York Times
He Was Expected to Get Alzheimer’s 25 Years Ago. Why Hasn’t He?
-
Stat
This scientist is revealing the immune system in our nasal passages
-
AP News
Music could help ease pain from surgery or illness. Scientists are listening
Oct 17, 2025
Oct 16, 2025
Oct 15, 2025
Oct 14, 2025
-
The Wall Street Journal
Why Biotech’s Rally Can Last This Time
-
MIT Technology Review
How aging clocks can help us understand why we age—and if we can reverse it
-
Healthcare Dive
Trump administration moves to fire HHS employees amid shutdown
-
The Financial Times
Mirador fundraising raises hopes of revival in US biotech market
Oct 10, 2025
-
The Washington Post
She left the medical mainstream and rose to be RFK Jr.’s surgeon general pick
-
Endpoints News
In China, a low-cost push to rival a life-saving, $2M medicine
-
Nature
Cancer cachexia contender enters first pivotal trial
-
Bloomberg
Europe Risks Losing Drug Access in Trump Plan, Ex-Novo CEO Warns
